Case Control Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. May 7, 2016; 22(17): 4362-4372
Published online May 7, 2016. doi: 10.3748/wjg.v22.i17.4362
Figure 1
Figure 1 Flow chart of the study population. NAFLD: Non-alcoholic fatty liver disease.
Figure 2
Figure 2 Distribution of self-rated health perception among non-alcoholic fatty liver disease and normal liver groups among the entire population (A), subjects with body mass index 27 and below (n = 95) and subjects with body mass index above 27 (n = 112) (B). P values represent the difference between NAFLD and normal liver groups in the distribution of “very good” health perception versus “else”- all other categories combined (Chi-square). NAFLD: Non-alcoholic fatty liver disease; BMI: Body mass index.
Figure 3
Figure 3 Univariate and multivariate association between non-alcoholic fatty liver disease and "very good" health perception (A) by non-alcoholic fatty liver disease diagnosed with regular US compared to normal liver (B) by hepato-renal index level (per one unit increase in the index) [odds ratio (95%CI)]. Model 1: Crude; Model 2: Adjusted for age and gender; Model 3: Adjusted for age, gender and BMI; NAFLD: Non-alcoholic fatty liver disease; BMI: Body mass index; HRI: Hepato-renal index.
Figure 4
Figure 4 Health perception by past and present diagnosis of fatty liver on ultrasound (never NAFLD n = 119, 1st US NAFLD n = 24, 2nd US NAFLD n = 28, both US NAFLD n = 42). A: Percent of subjects with “very good” health perception by NAFLD dynamics; B: Percent of subjects with “very good” health perception by naive (newly diagnosed) and not naive (previously diagnosed) NAFLD status; C: The average score of health perception by NAFLD dynamics (the lower the score the higher the health perception; 1 = “very good”, 4 = “not good at all”) (anever NAFLD vs every other group). NAFLD: Non-alcoholic fatty liver disease.
Figure 5
Figure 5 Comparison between non-alcoholic fatty liver disease and normal liver groups in the distribution of frequency of family doctor visits (A) and in the distribution of frequency of specialty consultants (B). NAFLD: Non-alcoholic fatty liver disease.